Page 33 - TD-3-4
P. 33
Tumor Discovery Expert consensus of NUT carcinoma
doi: 10.1016/j.bulcan.2022.01.015 doi: 10.1053/j.semnuclmed.2014.07.004
29. Charlab R, Racz R. The expanding universe of NUTM fusions 41. Gasljevic G, Matter MS, Blatnik O, Unk M, Dirnhofer S.
1
in pediatric cancer. Clin Transl Sci. 2023;16(8):1331-1339. NUT carcinoma: A clinical, morphological and
doi: 10.1111/cts.13535 immunohistochemical mimicker-the role of RNA
sequencing in the diagnostic procedure. Int J Surg Pathol.
30. Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic 2022;30(3):273-277.
features and long-term outcomes of NUT midline
carcinoma. Clin Cancer Res. 2012;18(20):5773-5779. doi: 10.1177/10668969211047981
doi: 10.1158/1078-0432.CCR-12-1153 42. Moreno V, Saluja K, Pina-Oviedo S. NUT carcinoma:
Clinicopathologic features, molecular genetics and
31. Virarkar M, Mallery M, Saleh M, Ramani NS, Morani AC, epigenetics. Front Oncol. 2022;12:860830.
Bhosale P. Clinical, radiographic, pathologic characterization
and survival outcomes of nuclear protein of the testis doi: 10.3389/fonc.2022.860830
carcinoma. J Comput Assist Tomogr. 2021;45(3):431-441. 43. French CA. NUT carcinoma: Clinicopathologic features,
doi: 10.1097/RCT.0000000000001163 pathogenesis, and treatment. Pathol Int. 2018;68(11):583-
595.
32. Polsani A, Braithwaite KA, Alazraki AL, Abramowsky C,
Shehata BM. NUT midline carcinoma: An imaging case series doi: 10.1111/pin.12727
and review of literature. Pediatr Radiol. 2012;42(2):205-210. 44. Allison DB, Rueckert J, Cornea V, Lee CY, Dueber J,
doi: 10.1007/s00247-011-2272-3 Bocklage T. Thyroid carcinoma with NSD3::NUTM1
fusion: A Case with thyrocyte differentiation and colloid
33. Lantuejoul S, Pissaloux D, Ferretti GR, McLeer A. NUT production. Endocr Pathol. 2022;33(2):315-326.
carcinoma of the lung. Semin Diagn Pathol. 2021;38(5):72-82.
doi: 10.1007/s12022-021-09700-2
doi: 10.1053/j.semdp.2021.06.005
45. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT
34. Nelson BA, Lee EY, French CA, Bauer DE, Vargas SO. BRD4- midline carcinoma using a NUT-specific monoclonal
NUT carcinoma of the mediastinum in a pediatric patient: antibody. Am J Surg Pathol. 2009;33(7):984-991.
Multidetector computed tomography imaging findings.
J Thorac Imaging. 2010;25(3):W93-W96. doi: 10.1097/PAS.0b013e318198d666
doi: 10.1097/RTI.0b013e3181b5d84d 46. McEvoy CR, Fox SB, Prall O. Emerging entities in NUTM1-
rearranged neoplasms. Genes Chromosomes Cancer.
35. Teo M, Crotty P, O’Sullivan M, French CA, Walshe JM. 2020;59(6):375-385.
NUT midline carcinoma in a young woman. J Clin Oncol.
2011;29(12):e336-e339. doi: 10.1002/gcc.22838
doi: 10.1200/JCO.2010.32.7486 47. French CA, Cheng ML, Hanna GJ, et al. Report of the first
international symposium on NUT carcinoma. Clin Cancer
36. Orman G, Masand P, Hicks J, Huisman TAGM, Res. 2022;28(12):2493-2505.
Guillerman RP. Pediatric thoracic mass lesions: Beyond the
common. Eur J Radiol Open. 2020;7:100240. doi: 10.1158/1078-0432.CCR-22-0591
doi: 10.1016/j.ejro.2020.100240 48. Huang Y, Durall RT, Luong NM, et al. EZH2 synergizes
with BRD4-NUT to drive NUT carcinoma growth through
37. Chen J, Li M, Lu H. Nuclear protein in testis carcinoma of silencing of key tumor suppressor genes. bioRxiv [Preprint].
the lung. Transl Oncol. 2023;30:101640. 2023.
doi: 10.1016/j.tranon.2023.101640 doi: 10.1101/2023.08.15.553204
38. Chang AI, Kim TS, Han J, Kim TJ, Choi JY. NUT midline 49. Barletta JA, Gilday SD, Afkhami M, et al. NUTM1 -rearranged
carcinoma of the lung: Computed tomography findings in carcinoma of the thyroid: A distinct subset of NUT
10 patients. J Comput Assist Tomogr. 2021;45(2):330-336. carcinoma characterized by frequent NSD3 - NUTM1
doi: 10.1097/RCT.0000000000001133 fusions. Am J Surg Pathol. 2022;46(12):1706-1715.
39. Huang W, Zhang Y, Yang Q, et al. Clinical imaging of doi: 10.1097/PAS.0000000000001967
primary pulmonary nucleoprotein of the testis carcinoma. 50. Alekseyenko AA, Walsh EM, Zee BM, et al. Ectopic
Front Med (Lausanne). 2022;9:1083206. protein interactions within BRD -chromatin
4
doi: 10.3389/fmed.2022.1083206 complexes drive oncogenic megadomain formation
in NUT midline carcinoma. Proc Natl Acad Sci U S A.
40. Davila D, Antoniou A, Chaudhry MA. Evaluation of
osseous metastasis in bone scintigraphy. Semin Nucl Med. 2017;114(21):E4184-E4192.
2015;45(1):3-15. doi: 10.1073/pnas.1702086114
Volume 3 Issue 4 (2024) 25 doi: 10.36922/td.4904

